Boston, MA · Founded 2022 · Privately Held (backing)
Developer of bifunctional small-molecule therapeutics designed to eliminate disease-driving cells. Solu Therapeutics is based in Boston, MA and was founded in 2022. Its last reported valuation was $104 million in Apr 2025. It has raised $72 million.
Last reported valuation
$104.0M
Oct 2026
Priced at
—
Total raised
$72.0M
Last round
—
Cap table — not yet on record
Solu Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Solu Therapeutics with a free account
·The complete investor list: 11 names
·Watch Solu Therapeutics: the Monday email on marks, rounds and moves
